Camron Bateman, OD
Optometrist · Salt Lake City, UTNPI 1902839905
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 54.5% of the total. Reporting peaked in 2019 at $3,638 and has fallen 73.3% since, to $971 in 2025. Among optometrist clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $96.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$6K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$1K
- Bausch & Lomb Americas Inc.$737
- Bausch & Lomb, A Division Of Bausch Health US, LLC$276
- Glaukos Corporation$198
- plus $907 from 8 others
What the payments were for
- Consulting fees$1,21812%
- Travel & lodging$3,90838%
- Food & beverage$4,96249%
- Gifts$691%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 35 | $5,531 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $1,319 |
| Alcon | 38 | $1,189 |
| Bausch & Lomb Americas Inc. | 11 | $737 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $276 |
| Glaukos Corporation | 1 | $198 |
| Coopervision Inc. | 2 | $194 |
| ABB Con-cise Optical Group LLC | 3 | $152 |
| Aerie Pharmaceuticals, Inc. | 1 | $123 |
| Tarsus Pharmaceuticals, Inc. | 1 | $121 |
| Biotissue Holdings Inc. | 1 | $111 |
| Lumenis, Inc | 1 | $103 |
| Harrow Eye, LLC | 1 | $84 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$4,796
- TearScience Lipiflow System$1,200
- TearScience Lipiview System$1,200
- TearScience Lipiscan System$1,200
- INFUSE$374
- BIOTRUE$250
- ULTRA$250
- BIOTRUE ONE DAY$250
- DAILIES TOTAL1$213
- iDoseTR$198
- Rhopressa$123
- Rocklatan$123
- MIEBO$123
- XIIDRA$123
- XDEMVY$121
- Prokera$111
- AmnioGraft$111
- TOTAL30$108
- Precision 1$108
How this compares
$10,157 in reported general payments places this provider in the 95th percentile of 423 optometrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 11 | $10,186 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Salt Lake City
- Sean CushmanSalt Lake City$25K
- Karri BureshSalt Lake City$9K
- Kaeleen FransonSalt Lake City$8K
- Leidy Dayan Monsalve-WardSalt Lake City$5K
- Rick RobisonSalt Lake City$4K
- Jeffrey SimmonsSalt Lake City$4K
- Ryan GarberSalt Lake City$4K
- Christopher ValliereSalt Lake City$3K
- Stephen ReinhartHill Afb$134K
- Robert WooldridgeMurray$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.